The electrophysiology devices and equipment market has seen considerable growth due to a variety of factors.
• In recent years, there has been a swift expansion in the market size of electrophysiology devices and equipment. It is predicted to escalate from its current $7.7 billion in 2024 to $8.73 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%.
Factors contributing to this growth during the historical period include the widespread incidence of cardiac arrhythmias, an aging population, the adoption of minimally invasive procedures, as well as clinical guidelines and research.
The electrophysiology devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for electrophysiology devices and equipment is projected to experience substantial growth in the coming years, with an estimation to reach $12.51 billion by 2029, advancing at a compound annual growth rate (CAGR) of 9.4%.
This growth during the prediction period can be linked to factors such as personalized medicine, telehealth integration, worldwide access to healthcare, and the use of electrophysiology devices in managing heart failure. Emerging trends expected to influence this market throughout the forecast period encompass 4D mapping and visualization, remote ablation procedures, hybrid procedures, and leadless cardiac pacing.
The upward trend in the occurrence of cardiovascular diseases (CVD) acts as a significant growth propellant for businesses in the electrophysiology devices and equipment market. As the principal cause of death worldwide, CVD is fostering a rise in the need for prompt and efficient disease management, leading to a surge in the demand for electrophysiology devices. These devices and equipment play a critical role in diagnosing, observing, and treating cardiovascular diseases, enhancing the need for specialized CVD healthcare. To illustrate, the Minnesota Department of Health, a US-based state health organization, released data in September 2024, that approximately 30% or about 1.4 million adults in Minnesota were reported to have high blood pressure in 2023. Moreover, in 2022, hypertension-related diseases accounted for 14,225 deaths, nearly 28% of the total deaths in the state. Hence, the escalating prevalence of cardiovascular diseases (CVD) continues to drive the electrophysiology devices and equipment market.
The electrophysiology devices and equipment market covered in this report is segmented –
1) By Product Type: Electrophysiology Ablation Catheters, Electrophysiology Diagnostic Catheters, Electrophysiology Lab Systems
2) By Monitoring Device Type: Electrocardiograph (ECG), Electroencephalograph (EEG), Electrocorticograph (ECoG), Electromyograph (EMG), Electroretinograph (ERG), Electrooculograph (EOG), Holter Monitoring Devices, X-Ray Systems, Imaging And 3D Mapping Systems, Diagnostic Electrophysiology Catheters
3) By Indication Analysis: Atrioventricular Nodal Reentry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), Atrial Flutter, Atrial Fibrillation
4) By End-Users: Hospitals, Diagnostic Centers, Clinics
Subsegments:
1) By Electrophysiology Ablation Catheters: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Ultrasound Ablation Catheters
2) By Electrophysiology Diagnostic Catheters: Mapping Catheters, Recording Catheters, Electrode Catheters
3) By Electrophysiology Lab Systems: 3D Mapping Systems, Electrophysiology Recording Systems, Cardiac Ablation Systems, Catheter Navigation Systems
Leading entities in the electrophysiology devices and equipment industry are actively developing novel devices and equipment through the application of innovative technology, such as mapping catheter integrating TRUEref Technology, to maintain their market dominance. A mapping catheter is a specialized medical tool applied in electrophysiology, especially in heart-related procedures. For example, Biosense Webster, Inc., a US firm specializing in the diagnosis and treatment of heart rhythm anomalies, introduced the OCTARAY Mapping Catheter incorporating TRUEref Technology in September 2022. This system offers enhanced performance and precision compared to its predecessors, establishing itself as a crucial tool for doctors in diagnosing and treating arrhythmias. The OCTARAY Mapping Catheter incorporates six rotating electrodes per spline, ensuring a higher degree of accuracy and detail in mapping arrhythmias in any heart chamber.
Major companies operating in the electrophysiology devices and equipment market include:
• Boston Scientific Corporation
• Abbott Laboratories
• GE Healthcare
• Philips Healthcare
• Biotronik SE & Co. KG
• Medtronic plc
• Biosense Webster Inc.
• Microport Scientific Corporation
• Japan Lifeline Co.
• C.R. Bard
• Mennen Medical Ltd.
• Harvard Bioscience Inc.
• HeNan HuaNan Medical Science and Technology Co. LTD.
• Nihon Kohden Corporation
• Alere Inc.
• MedRobotics
• Interface Biologics Inc.
• Meridian Health System Inc.
• Cardiva Medical Inc.
• Lombard Medical Technologies
• Deltex Medical Group
• Biotelemetry
• Bioheart Inc.
• Asahi Intecc Co. Ltd.
• Siemens Healthineers
• Lepu Medical Technology (Beijing) Co. Ltd
• Acutus Medical Inc.
• Imricor Medical Systems
• Johnson & Johnson
North America was the largest region in the global electrophysiology devices and equipment market in 2023. Western Europe was the second-largest region in the global electrophysiology devices and equipment market. The regions covered in the electrophysiology devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.